2002
DOI: 10.1074/jbc.m207145200
|View full text |Cite
|
Sign up to set email alerts
|

Serine Repeat Antigen (SERA5) Is Predominantly Expressed among the SERA Multigene Family of Plasmodium falciparum, and the Acquired Antibody Titers Correlate with Serum Inhibition of the Parasite Growth

Abstract: The Plasmodium falciparum serine repeat antigen (SERA) is one of the blood stage malaria vaccine candidates. The malaria genome project has revealed that SERA is a member of the SERA multigene family consisting of eight SERA homologues clustered on chromosome 2 and one SERA homologue on chromosome 9. Northern blotting and real time quantitative reverse transcription-PCR with five independent parasite strains, including three allelic representative forms of the SERA gene, have shown that all of the SERA homolog… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
100
0

Year Published

2010
2010
2016
2016

Publication Types

Select...
3
2
1

Relationship

3
3

Authors

Journals

citations
Cited by 94 publications
(105 citation statements)
references
References 40 publications
5
100
0
Order By: Relevance
“…During blood stage growth, all SERA gene family member of P. falciparum are transcribed most actively at trophozoite and schizont stages. SERA5 is the most abundantly expressed gene family member, with expression levels estimated to be approximately 0.5-1.5% of the whole mRNA at schizont stage (Aoki et al, 2002). However, sero-positivity rate against the Nterminal domain of P. falciparum SERA5 was observed to be relatively low (Fig.…”
Section: Conclusion and Open Issues In Sera Studymentioning
confidence: 99%
See 4 more Smart Citations
“…During blood stage growth, all SERA gene family member of P. falciparum are transcribed most actively at trophozoite and schizont stages. SERA5 is the most abundantly expressed gene family member, with expression levels estimated to be approximately 0.5-1.5% of the whole mRNA at schizont stage (Aoki et al, 2002). However, sero-positivity rate against the Nterminal domain of P. falciparum SERA5 was observed to be relatively low (Fig.…”
Section: Conclusion and Open Issues In Sera Studymentioning
confidence: 99%
“…In addition, a gene family member in P. falciparum, SERA5, is a vaccine candidate now on phase Ib clinical trial (Horii et al, 2010). Two observations promise SERA5 as a vaccine candidate: (1) SERA genes are not differently expressed like other antigen encoding gene families such as var and rifin that show antigenic variation to evade host immune response (Aoki et al, 2002;Miller et al, 2002;Palacpac et al, 2006;Schmidt-Christensen et al, 2008;Putrianti et al, 2010;Arisue et al, 2011); and (2) P. falciparum SERA5 is less polymorphic (Fox et al, 1997: Morimatsu et al, 1997Liu et al, 2000) than other vaccine candidate genes such as merozoite surface protein 1 (McBride et al, 1985) and apical membrane protein 1 (Polley et al, 2003;Cortés et al, 2003). These characteristics are indeed appealing and show the unique biological features of Plasmodium SERA.…”
Section: Introductionmentioning
confidence: 99%
See 3 more Smart Citations